← Human Trials & Peer-Reviewed Studies

Delivery of a Vitamin D Intervention in Homebound Older Adults Using a Meals-on-Wheels Program: A Pilot Study.

Plain-language guide to PMID 26277680 (2015): single-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.

Key Facts

PMID
26277680
Journal
Journal of the American Geriatrics Society
Year
2015
Study type
Randomized Controlled Trial
Authors
Houston DK et al. (8 authors)
DOI
10.1111/jgs.13610

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.

Who Took Part

PubMed indexes the participants as older adults, both men and women.

Community-dwelling homebound adults aged 65 to 102 (N = 68).

Serum 25(OH)D was assessed at baseline and 5-month follow-up; proportions of participants in 25(OH)D categories were compared using Fisher exact test.

How the Study Was Run

The researchers set it up as a randomized, single-blind, placebo-controlled and pilot study.

The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

Only one side, usually the participants, was kept unaware of whether Vitamin D, K2, Magnesium and Zinc was given.

Some participants received a placebo instead of Vitamin D, K2, Magnesium and Zinc, giving a reference point.

It is described as a pilot, a small early test of whether a larger Vitamin D, K2, Magnesium and Zinc study would be practical.

MOW, Forsyth County, North Carolina.

What Was Measured

Topics PubMed links to this paper include Accidental Falls, Cholecalciferol, Dietary Supplements, Feasibility Studies, Food Services, Homebound Persons and Pilot Projects.

The authors tagged it with the keywords 25-hydroxyvitamin D, Meals-on-Wheels and homebound older adults.

What This Means in Plain Language

The paper is a randomized, single-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.

The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2015 (Journal of the American Geriatrics Society), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.